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A new method for the preparation of smooth muscle thin filaments which include calponin was established. We found that calponin readily separat- 
ed from thin filaments in the presence of 10 mM ATP. By preventing thin filament extract from exposing to ATP, we obtained thin filaments 
which contained actin, tropomyosin, caldesmon and calponin in molar ratios of 7:0.9:0.6:0.7. We studied myosin Mg-ATPase activity by using 
the thin filaments in comparison with classical thin filaments prepared by the method of Marston and Smith, which contained the same amounts 
of caldesmon and tropomyosin as our thin filaments but lost almost all calponin. The presence of calponin reduced the V,, value for thin tilament- 
activated myosin Mg-ATPase activity by 33% without a significant change in K, value. These findings suggest hat calponin inhibits myosin Mg- 
ATPase activity by modulation of a kinetic step as an integral component of smooth muscle thin filaments. 
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1. INTRODUCTION 
There are two contractile assemblies in the 
myofibrils. One is thick filament and the other is thin 
filament. It is generally accepted that the hydrolysis of 
ATP drives muscle contraction by sliding both 
filaments each other and this process is controlled by 
Ca2 + concentration. The discovery of the phosphoryla- 
tion of 20 kDa light chain of smooth muscle myosin by 
the Ca2 + -calmodulin complex and its enhancement of 
Mg-ATPase activity made clear the role of thick fila- 
ment regulation in the initiation of Ca2 + -dependent 
contraction of smooth muscle [l-5]. Time-matched 
measurement of sarcoplasmic Ca2 + concentration, 
myosin light chain phosphorylation, stress and tension 
development in smooth muscle, however, did not sup- 
port the view that cross bridge phosphoryiation is essen- 
tial for the force m~nt~ning interaction between thick 
and thin filaments [6-91. 
et al. found an additional actin-binding and 
tropomyosin-binding component in many vertebrate 
smooth muscles [14,15]. This novel protein, named 
calponin, is postulated to be a potential regulator of 
thin filaments on the basis of observations that it shows 
immunological cross-reactivity with troponin-T 1161 
and it binds to tropomyosin at a specific site for the 
Ca2 + -sensitive binding of troponin-T to tropomyosin 
[17]. Calponin existed in equimolar concentration to 
tropomyosin in the muscle extract [14,16]. These obser- 
vations suggest hat calponin is an integral component 
of smooth muscle thin filaments. Recently, Tsunekawa 
et al. reported that a free form of calponin was one of 
the most susceptible substrate for calpain I, a 
C2 + -dependent cysteine endopeptidase, in the smooth 
muscle contractile proteins. When calponin was a 
bound form in thin filaments, it became markedly resis- 
tant to calpain digestion [ 181. This observation also sug- 
gests that calponin appears to be a constituent of 
smooth muscle thin filaments. 
It appears that an as yet unknown regulatory system 
(or systems) resides in the thin filaments. Caldesmon is 
proposed as one of the regulatory proteins in smooth 
muscle thin filaments [ 1 O- 131, Furthermore, Takahashi 
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The thin filaments were first prepared from 
vertebrate smooth muscle by Sobieszek, Small and co- 
workers [l]. Then, the method developed by Marston 
and Smith [19] has been the most commonly used for 
the preparation of smooth muscle thin filaments. 
Calponin, however, is lost during the preparation of 
thin filaments by their method and others [20]. 
Abbreviations: DTT, dithiothreitol; PMSF, phenylmethanesuiphonyl 
fluoride; Pipes, piperaxine-N,N’-bis; ATP[7s], adenosine 5’-f-y-thio] 
triphosphate 
In this report, we established a new method for the 
preparation of thin filaments which contain calponin. 
We also showed that calponin had an inhibitory effect 
on thin fluent-activated myosin Mg-ATPase activity. 
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2. MATERIALS AND METHODS 
2.1. Preparation of smooth muscle thin filaments 
Washed myofibrils and thin filament extract of smooth muscle 
were prepared according to the method of Marston and Smith [19] 
with a slight modification. Smooth muscle of fresh chicken gizzard 
was cut away from the inner lining and the external connective tissue 
sheath. All further steps were carried out at 4°C. The muscle tissue 
was thoroughly fragmented by mincing twice with a meat grinder. The 
minced smooth muscle was then homogenized in 4 vols 
(volume/weight of starting minced muscles) of 10 mM imidazole/HCl 
buffer (pH 7.0) containing 50 mM KCI, 5 mM MgC12, 1 mM EGTA, 
1 mM DTT, 1 mM NaNs, 10 pg/ml of leupeptin, 1 mM trypsin in- 
hibitor, 1 mM PMSF and 1 mM sodium tetrathionate dihydrate with 
home use blender for 30 s. The muscle residue was collected by cen- 
trifugation at 15 000 x g for 5 min. This washing step was repeated 
5 times. Triton X-100 was added in the washing solution in case of the 
first three steps with decreasing its concentration from 1% to 0.5% (1, 
1, 0.5%). 
Thin filaments were extracted from washed myofibrils. The finally 
washed pellet was gently blended in 2.5 vols (v/w) of 20 mM Pipes 
buffer (pH 6.1) containing 80 mM KCl, 5 mM MgCl2, 10 mM ATP, 
1 mM EGTA, 1 mM DTT and protease inhibitors described above 
with blender for 3 s and was left quiet for 1 h. Then the suspension 
was centrifuged at 15 000 x g for 30 min and thin filament extract 
was collected in supernatant. 
The extracted thin filaments were immediately dialysed against 100 
vols (v/v) of 20 mM imidazole/HCl buffer (pH 7.0) containing 80 
mM KCl, 0.5 mM MgC12, 0.5 mM DTT and 0.1 mM EGTA for 8 h 
at 4°C. The buffer was changed twice while dialysis for efficient 
elimination of ATP. After the dialysis, degenerated proteins were col- 
lected by the centrifugation at 30 000 x g and 30°C for 10 min. Final- 
ly, thin filaments were collected by high-speed sedimentation at 
150 000 + g and 30°C for 1 h. The precipitated pellet was resuspend- 
ed in an appropriate buffer. 
Marston and Smith’s thin filaments were purified from chicken giz- 
zard smooth muscle according to their original method [19]. 
2.2. Preparation of reconstituted thin filaments 
Calponin was added to Marston and Smith’s thin filaments to a 
final molar ratio of 5:l (calponin:actin). They were incubated at 37°C 
for 30 min in 20 mM imidazole/HCl buffer (pH 7.0) containing 80 
mM KCI, 0.5 mM MgC12, 0.5 mM DTT and 0.1 mM EGTA. 
Reconstituted thin filaments were collected by centrifugation at 
150 000 x g and 30°C for 1 h. Densitometric analysis of SDS- 
polyacrylamide gel electrophoresis of the reconstituted thin filaments 
showed that actin, tropomyosin, caldesmon and calponin were pre- 
sent in molar ratios of 7:0.8:0.4:0.7. 
2.3. Preparations of other smooth muscle proteins 
Smooth muscle myosin was purified from chicken gizzard using the 
method of Persechini et al., [21] and it was thiophosphorylated accor- 
ding to the method of Heaslip and Chacko [22]. The extent of 
phosphorylation was confirmed by urea gel electrophoresis. Smooth 
muscle calponin was purified from chicken gizzard by the method 
described previously [23]. 
2.4. Miscellaneous procedures 
SDS-polyacrylamide slab gel electrophoresis (12.5% w/v) was per- 
formed using the buffer system of Laemmli [24]. For the separation 
of P-tropomyosin from actin, gel electrophoresis was carried out in 
the presence of 2 mM CaCl2 [25]. After the electrophoresis, the gel 
was stained with 0.25% Coomassie brilliant blue R-250 and was 
scanned using a microdensitometer. The molar ratios of each stained 
protein were estimated by the calibration with purified smooth muscle 
proteins. Molecular masses of actin, tropomyosin (a! and 0, calponin 
and caldesmon were taken to be 43 000, 35 000, 34 000 and 87 000, 
respectively. The molecular mass of caldesmon, 87 000 was based on 
the primary structure of caldesmon [26], although its estimated 
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molecular mass from SDS gel electrophoresis was 120 000-150 000. 
Protein concentration was measured by the method of Bradford [27]. 
2.5. Measurement of myosin Mg-ATPase activity 
Myosin used in this experiment was thiophosphorylated by ATP- 
[+I to eliminate the possibility of dephosphorylation by contaminant 
phosphatase. We confirmed that there was no significant change in 
the extent of phosphorylation of myosin throughout he experimental 
procedures. 
Myosin Mg-ATPase activity was measured at 37°C in 20 mM im- 
idazole/HCl buffer @H 7.0) containing 90 mM KCI, 4 mM MgCLZ, 
1 mM DTT, 0.2 mM CaCl2, 1 gM thiophosphorylated myosin and 
O-70 a thin filaments (in terms of actin monomer). Each sample was 
preincubated at 37°C for 5 min. The reaction was initiated by addi- 
tion of ATP (final concentration, 2 mM) and terminated after 10 min 
by trichioroacetic acid (final concentration, 7%). Released inorganic 
phosphate was measured by the method ofFiske and SubbaRow [28]. 
Control samples containing the thin filaments alone were run at the 
same time for a correction of background activity of the thin 
filaments. To get a net ATPase activity, myosin Mg-ATPase activity 
in the absence of thin filaments was also subtracted from each 
measurement made in the presence of thin filaments. 
3. RESULTS 
3.1. Thin filaments from chicken gizzard smooth 
muscle 
Fig. 1 shows SDS-polyacrylamide gel electrophoresis 
(12.5%) of two kinds of thin filaments extracted from 
chicken gizzard smooth muscle. Whole homogenate 
(Fig. 1, lane l), washed myofibrils (Fig. 1, lane 2) and 
thin filament extract (Fig. 1, lane 3) contained calponin. 
But there was only a trace of calponin in thin filaments 
prepared by the method of Marston and Smith (Fig. 1, 
lane 5). They contained actin, tropomyosin, caldesmon 
and calponin in molar ratios of 7:0.8:0.5:0.01. In con- 
trast, thin filaments prepared by our method contained 
substantial amounts of calponin (Fig. 1, lane 4) and the 
molar ratios were 7:0.9:0.6:0.7 (the same order describ- 
ed above). The molar ratios of major proteins in 
reconstituted thin filaments (7:0.8:0.4:0.7) were very 
close to our thin filaments. 
The yields of thin filaments prepared by our method 
and by Marston and Smith’s method were 4-6 mg and 
2-3 mg per gram of minced smooth muscle tissue, 
respectively. 
3.2. Effect of thin filaments on myosin Mg-A TPase 
activity 
Both thin filaments activated myosin Mg-ATPase ac- 
tivity in a dose-dependent manner. Fig. 2 shows a 
representative xperiment. The data were fitted to the 
Michaelis-Menten equation. V,,,,, value for our thin 
filaments was 162 f 18 nmol Pi/min/+g of myosin 
(n = 4) and that for Marston and Smith’s thin filaments 
was 242 k26 nmol Pi/min/mg of myosin (n =4). K, 
value for our thin filaments was 4.2a0.9 PM (n=4) 
and that for Marston and Smith’s thin filaments 
was 4.0rt0.5 PM (n =4). Apparent binding constant 
(KATPase) values [29], reciprocal number of K,, for our 
filaments and for Marston and Smith’s thin filaments 
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Fig. 1. SDS-polyacrylamide gel electrophoresis (12.5%). The gel in- 
cluded 2 mM CaC12 for the separation of fi-tropomyosin from actin. 
(Lane 1) whole homogenate; (lane 2) washed myofibrils; (land 3) thin 
filament extract; (land 4) thin filaments prepared by our method; 
(lane 5) thin filaments prepared by Marston and Smith’s method. M, 
myosin; CD, caldesmon; A, actin; TM, tropomyosin (0~ and 6); CN, 
calponin. 
were2.4~0.5x105M-1and2.5~0.2x105M-1.Since 
our thin filaments and those of Marston and Smith con- 
tain the same amounts of caldesmon and tropomyosin 
in relation to actin monomer, the difference in the 
kinetic parameters between the two thin filaments must 
be due to the presence of calponin in our thin filaments. 
This was confirmed by the reconstitutive experiment 
which showed that the kinetic parameters of Marston 
and Smith’s thin filaments supplemented by calponin in 
molar ratio of actin to calponin 7:0.7 were very similar 
to those of our native thin filaments (V,, 171 a 19 
nmol Pi/min/mg of myosin, Km 3.8+ 1.1 PM and 
2.6*0.6x lo5 M-’ (n=4)). 
.Z 
E Thin Filaments (pM) 
Fig. 2. Effects of 3 kinds of thin filaments on myosin Mg-ATPase ac- 
tivity. Conditions: 37”C, 20 mM imidazole-HCl (pH 7.0), 90 mM 
KCl, 4 mM MgC12, 1 mM DTT, 0.2 mM CaCla, 1 CM 
thiophosphorylated myosin and O-70 FM thin filaments. Marston and 
Smith’s thin filaments (A), thin filaments including calponin 
prepared by our method (0) and Marston and Smith’s thin filaments 
supplemented by calponin (0). 
4. DISCUSSION 
Using our preparative procedures for smooth muscle 
thin filaments, we demonstrated that thin filaments 
consisting of actin, tropomyosin, caldesmon and 
calponin could be purified from chicken gizzard 
smooth muscle. Lehman has reported that calponin 
does not appear to be a constituent of smooth muscle 
thin filaments [20]. We found that this discrepancy was 
due to the presence or absence of ATP in the 
preparative procedures. A high concentration of ATP 
readily liberated calponin from thin filaments. We ob- 
tained successful preparations of thin filaments which 
contain substantial amounts of calponin by preventing 
thin filament extract from exposing to ATP in further 
steps. The amount of calponin in the thin filaments 
prepared by our procedures was 70 times greater than 
that in the widely used thin filaments prepared by the 
method of Marston and Smith [19]. The present result 
and our previous findings [ 14- 181 indicate that calponin 
is an integral component of smooth muscle thin 
filaments and it may serve as a regulator for smooth 
muscle contraction. The presence of calponin in thin 
filaments caused 33% reduction in I’,,,,, for the myosin 
Mg-ATPase activity by native thin filaments as well as 
reconstituted thin filaments in comparison with thin 
filaments which are devoid of calponin. The reduction 
of V,,,,, was achieved without a significant change in K,,, 
and KATP~~~ value. These results suggest that, like 
troponin-tropomyosin system in striated muscle, the in- 
hibitory effect of calponin on Mg-ATPase activity of 
smooth muscle myosin is not due to a change in the af- 
finity of myosin to thin filaments, but to a change in 
other steps such as phosphate and ADP release in the 
kinetic cycle. 
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